Lebrikizumab▼: Short and Long-Term Disease Control in Moderate-to-Severe AD Through Selective IL-13 Inhibition
-
Published:2024-09-12
Issue:
Volume:
Page:46-47
-
ISSN:2397-6764
-
Container-title:European Medical Journal
-
language:
-
Short-container-title:EMJ
Publisher
European Medical Group